Matrix metalloproteinases 2 and 9 are elevated in human preterm laboring uterine myometrium and exacerbate uterine contractility†
Open Access
- 5 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 100 (6) , 1597-1604
Abstract
Matrix metalloproteinases 2 and 9 (MMP2/9) have previously been shown to be elevated in serum and amniotic fluid from women undergoing preterm birth. We performed experiments to determine the effects of MMP2/9 on uterine contraction and birth timing. Pregnant mice were injected daily with 50 mg/kg of SB-3CT or vehicle control beginning on gestational day 14–18 to determine if MMP2/9 inhibition would affect parturition timing. MMP2/9 expression in human myometrial tissue was determined by Simple Western (Wes) and semiquantitative western blot. Purified MMP2/9 and SB-3CT inhibitor were added to human myometrial strips to determine the effects of MMP2/9 on oxytocin-induced uterine contraction. Parturition was delayed in mice treated with MMP2/9 inhibitor SB-3CT. MMP2/9 protein levels were elevated in preterm laboring uterine myometrium. Gelatinase activity was confirmed in cell extracts and supernatants from immortalized and primary human uterine myometrial cells in culture. Addition of purified MMP2/9 increased the oxytocin-induced contractile response in myometrial tissue strips from pregnant women. In contrast, addition of the MMP2/9 inhibitor SB-3CT decreased the contractile response to oxytocin in a dose-dependent manner. These results suggest abnormal MMP2/9 expression affects the contractile state of the uterine myometrium to promote parturition and that MMP2/9 inhibition attenuates this effect.Keywords
Funding Information
- National Institute of General Medical Sciences (NIH 1U54GM104944)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH R00HD067342)
This publication has 61 references indexed in Scilit:
- Metalloproteinases and their natural inhibitors in inflammation and immunityNature Reviews Immunology, 2013
- Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm LaborPLOS ONE, 2012
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contractionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- The Effects of Prostaglandin E1 and Prostaglandin E2 on in vitro Myometrial Contractility and Uterine StructureAmerican Journal of Perinatology, 2012
- A Standardized Template for Clinical Studies in Preterm BirthReproductive Sciences, 2012
- Cervical Remodeling/Ripening at Term and Preterm Delivery: The Same Mechanism Initiated by Different Mediators and Different Effector CellsPLOS ONE, 2011
- Complement Activation Triggers Metalloproteinases Release Inducing Cervical Remodeling and Preterm Birth in MiceThe American Journal of Pathology, 2011
- MMP-2 Induced Vein Relaxation via Inhibition of [Ca2+]e-Dependent Mechanisms of Venous Smooth Muscle Contraction. Role of RGD PeptidesJournal of Surgical Research, 2010
- Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm laborReproductive Biology and Endocrinology, 2010